Ziad Ismael, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Brooks Ln, Suite 180, Jefferson Hills, PA 15025 Phone: 412-469-3600 Fax: 412-469-3630 |
Tobi Lynn Shuman, DO Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Brooks Lane, Suite 180, Jefferson Hills, PA 15025 Phone: 412-469-3600 Fax: 412-469-3630 |
News Archive
Publishing in the September issue of the Journal of Gerontology: Psychological Sciences, University of South Florida School of Aging Studies researcher Ross Andel and James Mortimer, professor, USF College of Public Health, examined the relationship between complexity of main lifetime occupation and risk for Alzheimer's disease and dementia in general.
Scientists at Indiana University, Methodist Research Institute study a botanical formula that kills aggressive prostate cancer tumors. Their findings, based on experiments in mice using a human prostate cancer tumor model, appear online in The International Journal of Oncology.
Results from a health economic substudy of the TRITON-TIMI 38 clinical trial showed that among patients with acute coronary syndromes (ACS) managed with percutaneous coronary intervention (PCI), including stenting, treatment with Effient(®) (prasugrel) compared with branded clopidogrel (Plavix(®)) was more cost effective, and in most cases cost saving.
New research being presented this week is giving scientists new insight into why a restricted diet can lead to a longer lifespan and reduced incidence of age-related diseases for a wide variety of animals. Scientists have known for some time that a restricted diet can extend the lifespan of certain animals but this work shows how it affects ageing mechanisms - and significantly has also shown that the effects occur even if the restricted diet is adopted later in life.
Covidien, a leading global provider of healthcare products, today announced it supports the U.S. Food and Drug Administration's (FDA) labeling changes for gadolinium-based contrast agents for patients with acute kidney injury or chronic, severe kidney disease.
› Verified 7 days ago